EMD-27508

Single-particle
2.25 Å
EMD-27508 Deposition: 08/07/2022
Map released: 31/08/2022
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links

EMD-27508

Cryo-EM structure of SARS-CoV-2 Gamma (P.1) spike protein

EMD-27508

Single-particle
2.25 Å
EMD-27508 Deposition: 08/07/2022
Map released: 31/08/2022
Last modified: 20/11/2024
Overview 3D View Sample Experiment Validation Volume Browser Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2
Sample: SARS-CoV-2 Gamma (P.1) spike protein
Fitted models: 8dlo (Avg. Q-score: 0.472)

Deposition Authors: Zhu X, Mannar D, Saville JW, Srivastava SS , Berezuk AM , Zhou S, Tuttle KS, Subramaniam S
SARS-CoV-2 variants of concern: spike protein mutational analysis and epitope for broad neutralization.
PUBMED: 35982054
DOI: doi:10.1038/s41467-022-32262-8
ISSN: 2041-1723
Abstract:
Mutations in the spike glycoproteins of SARS-CoV-2 variants of concern have independently been shown to enhance aspects of spike protein fitness. Here, we describe an antibody fragment (VH ab6) that neutralizes all major variants including the recently emerged BA.1 and BA.2 Omicron subvariants, with a unique mode of binding revealed by cryo-EM studies. Further, we provide a comparative analysis of the mutational effects within previously emerged variant spikes and identify the structural role of mutations within the NTD and RBD in evading antibody neutralization. Our analysis shows that the highly mutated Gamma N-terminal domain exhibits considerable structural rearrangements, partially explaining its decreased neutralization by convalescent sera. Our results provide mechanistic insights into the structural, functional, and antigenic consequences of SARS-CoV-2 spike mutations and highlight a spike protein vulnerability that may be exploited to achieve broad protection against circulating variants.